Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MinimuMM-seq: Genome Sequencing of Circulating Tumor Cells for Minimally Invasive Molecular Characterization of Multiple Myeloma Pathology.
Dutta AK, Alberge JB, Lightbody ED, Boehner CJ, Dunford A, Sklavenitis-Pistofidis R, Mouhieddine TH, Cowan AN, Su NK, Horowitz EM, Barr H, Hevenor L, Beckwith JB, Perry J, Cao A, Lin Z, Kuhr FK, Mastro RGD, Nadeem O, Greipp PT, Stewart C, Auclair D, Getz G, Ghobrial IM. Dutta AK, et al. Among authors: greipp pt. Cancer Discov. 2023 Feb 6;13(2):348-363. doi: 10.1158/2159-8290.CD-22-0482. Cancer Discov. 2023. PMID: 36477267
Conditional survival in multiple myeloma and impact of prognostic factors over time.
Abdallah NH, Smith AN, Geyer S, Binder M, Greipp PT, Kapoor P, Dispenzieri A, Gertz MA, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Hwa YL, Lin Y, Kourelis T, Warsame R, Kyle RA, Rajkumar SV, Kumar SK. Abdallah NH, et al. Among authors: greipp pt. Blood Cancer J. 2023 May 15;13(1):78. doi: 10.1038/s41408-023-00852-4. Blood Cancer J. 2023. PMID: 37188699 Free PMC article.
Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.
Gagnon MF, Penheiter AR, Harris F, Sadeghian D, Johnson SH, Karagouga G, McCune A, Zepeda-Mendoza C, Greipp PT, Xu X, Ketterling RP, McPhail ED, King RL, Peterson JF, Vasmatzis G, Baughn LB. Gagnon MF, et al. Among authors: greipp pt. Blood Cancer J. 2023 Dec 19;13(1):190. doi: 10.1038/s41408-023-00967-8. Blood Cancer J. 2023. PMID: 38114462 Free PMC article. No abstract available.
Mate pair sequencing outperforms fluorescence in situ hybridization in the genomic characterization of multiple myeloma.
Smadbeck J, Peterson JF, Pearce KE, Pitel BA, Figueroa AL, Timm M, Jevremovic D, Shi M, Stewart AK, Braggio E, Riggs DL, Bergsagel PL, Vasmatzis G, Kearney HM, Hoppman NL, Ketterling RP, Kumar S, Rajkumar SV, Greipp PT, Baughn LB. Smadbeck J, et al. Among authors: greipp pt. Blood Cancer J. 2019 Dec 16;9(12):103. doi: 10.1038/s41408-019-0255-z. Blood Cancer J. 2019. PMID: 31844041 Free PMC article.
Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response.
Abdallah N, Rajkumar SV, Greipp P, Kapoor P, Gertz MA, Dispenzieri A, Baughn LB, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Go RS, Hwa YL, Fonder A, Hobbs M, Lin Y, Leung N, Kourelis T, Warsame R, Siddiqui M, Lust J, Kyle RA, Bergsagel L, Ketterling R, Kumar SK. Abdallah N, et al. Blood Cancer J. 2020 Aug 11;10(8):82. doi: 10.1038/s41408-020-00348-5. Blood Cancer J. 2020. PMID: 32782240 Free PMC article.
Utility of flow cytometry screening before MRD testing in multiple myeloma.
Panakkal V, Lakshman A, Shi M, Olteanu H, Horna P, Timm MM, Otteson GE, Baughn LB, Greipp PT, Gonsalves WI, Kapoor P, Gertz MA, Binder M, Buadi FK, Dispenzieri A, Rajkumar SV, Kumar SK, Jevremovic D. Panakkal V, et al. Among authors: greipp pt. Blood Cancer J. 2023 Apr 20;13(1):55. doi: 10.1038/s41408-023-00832-8. Blood Cancer J. 2023. PMID: 37080968 Free PMC article. No abstract available.
Anti-CD20 monoclonal antibody therapy in multiple myeloma.
Kapoor P, Greipp PT, Morice WG, Rajkumar SV, Witzig TE, Greipp PR. Kapoor P, et al. Among authors: greipp pt, greipp pr. Br J Haematol. 2008 Apr;141(2):135-48. doi: 10.1111/j.1365-2141.2008.07024.x. Epub 2008 Mar 3. Br J Haematol. 2008. PMID: 18318769 Free article. Review.
Natural history of multiple myeloma with de novo del(17p).
Lakshman A, Painuly U, Rajkumar SV, Ketterling RP, Kapoor P, Greipp PT, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Dispenzieri A, Fonder AL, Hayman SR, Hobbs MA, Gonsalves WI, Hwa YL, Leung N, Go RS, Lin Y, Kourelis TV, Warsame R, Lust JA, Russell SJ, Zeldenrust SR, Kyle RA, Kumar SK. Lakshman A, et al. Among authors: greipp pt. Blood Cancer J. 2019 Mar 7;9(3):32. doi: 10.1038/s41408-019-0191-y. Blood Cancer J. 2019. PMID: 30846679 Free PMC article.
Prognostic significance of acquired 1q22 gain in multiple myeloma.
Audil HY, Cook JM, Greipp PT, Kapoor P, Baughn LB, Dispenzieri A, Gertz MA, Buadi FK, Lacy MQ, Dingli D, Fonder AL, Hayman SR, Hobbs MA, Muchtar E, Siddiqui M, Gonsalves WI, Hwa YL, Leung N, Lin Y, Kourelis TV, Warsame R, Kyle RA, Ketterling RP, Rajkumar SV, Kumar SK. Audil HY, et al. Among authors: greipp pt. Am J Hematol. 2022 Jan 1;97(1):52-59. doi: 10.1002/ajh.26391. Epub 2021 Nov 3. Am J Hematol. 2022. PMID: 34710241 Free article.
172 results